Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Paxil – SSRI for the Treatment of Major Depressive Disorders

Drug (Brand/Generic):

Paxil/(paroxetine hydrochloride)

Company/Licensee:

GSK

Therapy Class:

Antidepressant

Product Description:

Selective serotonin reuptake inhibitor (SSRI)

Current Indication:

Major depressive disorders

Market Sector:

Psychiatry/psychology

Development Status:

On the market
Expand

Go Top